中西医结合心脑血管病杂志
中西醫結閤心腦血管病雜誌
중서의결합심뇌혈관병잡지
CHINESE JOURNAL OF INTEGRATIVE MEDICINE ON CARDIO-/CEREBROVASCULAR DISEASE
2014年
9期
1037-1038
,共2页
心力衰竭%三味檀香散%心功能分级%N末端B型脑钠肽前体
心力衰竭%三味檀香散%心功能分級%N末耑B型腦鈉肽前體
심력쇠갈%삼미단향산%심공능분급%N말단B형뇌납태전체
heart failure%Sanwei Tanxiang powder%curative effect%NT proBNP
目的：研究藏药三味檀香散治疗心力衰竭的临床疗效。方法分析我院收治的心力衰竭患者76例，分为治疗组及对照组。治疗组在常规药物治疗基础上加三味檀香散，对照组采用常规药物治疗，通过纽约心脏病协会(NYHA)心功能分级及 N 末端B型脑钠肽前体(NT proBNP)变化比较两组治疗效果。结果 NYHA心功能分级：治疗组总有效率为94.74%，对照组总有效率为76.32%，治疗组效果显著高于对照组(P<0.05)。NT proBNP：两组治疗后 NT proBNP 均有明显下降(P<0.05)，但治疗组下降更明显(P<0.05)。结论三味檀香散治疗心力衰竭安全有效。
目的：研究藏藥三味檀香散治療心力衰竭的臨床療效。方法分析我院收治的心力衰竭患者76例，分為治療組及對照組。治療組在常規藥物治療基礎上加三味檀香散，對照組採用常規藥物治療，通過紐約心髒病協會(NYHA)心功能分級及 N 末耑B型腦鈉肽前體(NT proBNP)變化比較兩組治療效果。結果 NYHA心功能分級：治療組總有效率為94.74%，對照組總有效率為76.32%，治療組效果顯著高于對照組(P<0.05)。NT proBNP：兩組治療後 NT proBNP 均有明顯下降(P<0.05)，但治療組下降更明顯(P<0.05)。結論三味檀香散治療心力衰竭安全有效。
목적：연구장약삼미단향산치료심력쇠갈적림상료효。방법분석아원수치적심력쇠갈환자76례，분위치료조급대조조。치료조재상규약물치료기출상가삼미단향산，대조조채용상규약물치료，통과뉴약심장병협회(NYHA)심공능분급급 N 말단B형뇌납태전체(NT proBNP)변화비교량조치료효과。결과 NYHA심공능분급：치료조총유효솔위94.74%，대조조총유효솔위76.32%，치료조효과현저고우대조조(P<0.05)。NT proBNP：량조치료후 NT proBNP 균유명현하강(P<0.05)，단치료조하강경명현(P<0.05)。결론삼미단향산치료심력쇠갈안전유효。
Objective To study the curative effect of Tibetan medicine Sanwei Tanxiang powder(STP)for the treatment of heart failure.Methods Seventy six patients with heart failure were randomly divided into two groups:Treatment group treated with con-ventional treatment plus STP,and control group treated with conventional treatment.The NYHA heart function classification and the level of NT proBNP were compared in two groups.Results Total effective rate was 94.74% in treatment group and 76.32% in control group (P<0.05).The level of NT proBNP was significantly decreased in two groups after treatment (P<0.05),that in the treatment group was decreased more obviously (P<0.05).Conclusion STP was safe and effective in treatment of heart failure.
